Title |
Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase–lowering effects of garlic in patients with type 2 diabetes mellitus with obesity
|
---|---|
Published in |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, January 2013
|
DOI | 10.2147/dmso.s38888 |
Pubmed ID | |
Authors |
Rahat Kumar, Simran Chhatwal, Sahiba Arora, Sita Sharma, Jaswinder Singh, Narinder Singh, Vikram Bhandari, Ashok Khurana |
Abstract |
Type 2 diabetes mellitus is a chronic disorder characterized by chronic hyperglycemia, with long term macrovascular and microvascular complications. The treatment is lifestyle management, exercise, weight control, and antihyperglycemic drugs such as sulfonylureas, biguanides, alpha-glucosidase inhibitors, thiazolidinediones, and meglitinide. Recently, a direct association between high levels of C-reactive protein and serum adenosine deaminase levels in patients with uncontrolled diabetes with long-term complications has been seen. This study was conducted to assess the antihyperglycemic, lipid-lowering, anti-inflammatory, and improving glycemic control of garlic in type 2 diabetes patients with obesity. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Portugal | 1 | <1% |
Brazil | 1 | <1% |
Canada | 1 | <1% |
Iran, Islamic Republic of | 1 | <1% |
United States | 1 | <1% |
Unknown | 167 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 26 | 15% |
Student > Bachelor | 26 | 15% |
Student > Ph. D. Student | 13 | 8% |
Other | 12 | 7% |
Researcher | 12 | 7% |
Other | 30 | 17% |
Unknown | 53 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 41 | 24% |
Biochemistry, Genetics and Molecular Biology | 16 | 9% |
Nursing and Health Professions | 14 | 8% |
Agricultural and Biological Sciences | 12 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 9 | 5% |
Other | 19 | 11% |
Unknown | 61 | 35% |